End-of-day quote
Korea S.E.
06:00:00 2024-07-02 pm EDT
|
5-day change
|
1st Jan Change
|
2,965
KRW
|
-1.66%
|
|
-3.42%
|
-46.67%
|
Fiscal Period: December |
2021
|
2022
|
2023
|
---|
Capitalization
1 |
201,381
|
116,027
|
71,664
|
Enterprise Value (EV)
1 |
184,281
|
92,565
|
60,681
|
P/E ratio
|
-23.8
x
|
-11.8
x
|
-5.52
x
|
Yield
|
-
|
-
|
-
|
Capitalization / Revenue
|
28.1
x
|
10.5
x
|
16.5
x
|
EV / Revenue
|
25.7
x
|
8.4
x
|
13.9
x
|
EV / EBITDA
|
-23.9
x
|
-12.6
x
|
-5.02
x
|
EV / FCF
|
-
|
15,961,656
x
|
-5,577,282
x
|
FCF Yield
|
-
|
0%
|
-0%
|
Price to Book
|
5.92
x
|
4.6
x
|
4.4
x
|
Nbr of stocks (in thousands)
|
12,431
|
12,503
|
12,889
|
Reference price
2 |
16,200
|
9,280
|
5,560
|
Announcement Date
|
3/23/23
|
3/23/23
|
3/20/24
|
Fiscal Period: December |
2021
|
2022
|
2023
|
---|
Net sales
1 |
7,163
|
11,018
|
4,351
|
EBITDA
1 |
-7,702
|
-7,325
|
-12,081
|
EBIT
1 |
-8,732
|
-8,599
|
-13,425
|
Operating Margin
|
-121.9%
|
-78.05%
|
-308.56%
|
Earnings before Tax (EBT)
1 |
-8,431
|
-9,839
|
-13,175
|
Net income
1 |
-8,431
|
-9,785
|
-12,769
|
Net margin
|
-117.7%
|
-88.82%
|
-293.48%
|
EPS
2 |
-682.0
|
-784.2
|
-1,007
|
Free Cash Flow
|
-
|
5,799
|
-10,880
|
FCF margin
|
-
|
52.64%
|
-250.07%
|
FCF Conversion (EBITDA)
|
-
|
-
|
-
|
FCF Conversion (Net income)
|
-
|
-
|
-
|
Dividend per Share
|
-
|
-
|
-
|
Announcement Date
|
3/23/23
|
3/23/23
|
3/20/24
|
Fiscal Period: December |
2021
|
2022
|
2023
|
---|
Net Debt
1 |
-
|
-
|
-
|
Net Cash position
1 |
17,100
|
23,462
|
10,983
|
Leverage (Debt/EBITDA)
|
-
|
-
|
-
|
Free Cash Flow
|
-
|
5,799
|
-10,880
|
ROE (net income / shareholders' equity)
|
-
|
-33.2%
|
-61.9%
|
ROA (Net income/ Total Assets)
|
-
|
-10.7%
|
-17%
|
Assets
1 |
-
|
91,063
|
74,908
|
Book Value Per Share
2 |
2,735
|
2,020
|
1,264
|
Cash Flow per Share
2 |
1,311
|
1,988
|
1,495
|
Capex
1 |
3,023
|
1,029
|
386
|
Capex / Sales
|
42.2%
|
9.34%
|
8.88%
|
Announcement Date
|
3/23/23
|
3/23/23
|
3/20/24
|
|
1st Jan change
|
Capi.
|
---|
| -46.67% | 28.05M | | -10.29% | 11.38B | | -20.75% | 6.83B | | +5.45% | 5.52B | | +28.32% | 5.44B | | -21.94% | 3.62B | | +6.32% | 2.56B | | -66.49% | 2.26B | | +30.36% | 2.24B | | -12.28% | 2.13B |
Diagnostic & Testing Substances
|